Rights and permissions
About this article
Cite this article
Current second-line agents have limited long term efficacy in RA …. Inpharma Wkly. 688, 2 (1989). https://doi.org/10.1007/BF03319732
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03319732